Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Bmi1 knockdown inhibits hepatocarcinogenesis.

Ruan ZP, Xu R, Lv Y, Tian T, Wang WJ, Guo H, Nan KJ.

Int J Oncol. 2013 Jan;42(1):261-8. doi: 10.3892/ijo.2012.1693. Epub 2012 Nov 9.

PMID:
23138990
[PubMed - indexed for MEDLINE]
2.

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Xie C, Song LB, Wu JH, Li J, Yun JP, Lai JM, Xie DY, Lin BL, Yuan YF, Li M, Gao ZL.

PLoS One. 2012;7(7):e40607. doi: 10.1371/journal.pone.0040607. Epub 2012 Jul 16.

PMID:
22815774
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
[PubMed - indexed for MEDLINE]
4.

Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.

Xu CR, Lee S, Ho C, Bommi P, Huang SA, Cheung ST, Dimri GP, Chen X.

Mol Cancer Res. 2009 Dec;7(12):1937-45. doi: 10.1158/1541-7786.MCR-09-0333. Epub 2009 Nov 24.

PMID:
19934271
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.

Li Y, Zhu Z, Zhang S, Yu D, Yu H, Liu L, Cao X, Wang L, Gao H, Zhu M.

PLoS One. 2011 Mar 15;6(3):e17794. doi: 10.1371/journal.pone.0017794.

PMID:
21423629
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.

Sasaki M, Ikeda H, Itatsu K, Yamaguchi J, Sawada S, Minato H, Ohta T, Nakanuma Y.

Lab Invest. 2008 Aug;88(8):873-82. doi: 10.1038/labinvest.2008.52. Epub 2008 Jun 30.

PMID:
18591938
[PubMed - indexed for MEDLINE]
Free Article
7.

The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.

Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y, Yonemitsu Y, Yokosuka O, Taniguchi H, Nakauchi H, Iwama A.

Cancer Res. 2008 Oct 1;68(19):7742-9. doi: 10.1158/0008-5472.CAN-07-5882.

PMID:
18829528
[PubMed - indexed for MEDLINE]
Free Article
8.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

PMID:
22028922
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
[PubMed - indexed for MEDLINE]
10.

A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.

Su J, You P, Zhao JP, Zhang SL, Song SH, Fu ZR, Ye LW, Zi XY, Xie DF, Zhu MH, Hu YP.

Med Oncol. 2012 Jun;29(2):1059-67. doi: 10.1007/s12032-011-9989-6. Epub 2011 Jun 8.

PMID:
21656028
[PubMed - indexed for MEDLINE]
11.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

PMID:
20846397
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.

Gan L, Guo K, Li Y, Kang X, Sun L, Shu H, Liu Y.

Oncol Rep. 2010 Apr;23(4):1037-43.

PMID:
20204289
[PubMed - indexed for MEDLINE]
13.

Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase.

Chuma M, Sakamoto N, Nakai A, Hige S, Nakanishi M, Natsuizaka M, Suda G, Sho T, Hatanaka K, Matsuno Y, Yokoo H, Kamiyama T, Taketomi A, Fujii G, Tashiro K, Hikiba Y, Fujimoto M, Asaka M, Maeda S.

Carcinogenesis. 2014 Feb;35(2):272-81. doi: 10.1093/carcin/bgt343. Epub 2013 Oct 15.

PMID:
24130164
[PubMed - indexed for MEDLINE]
14.

ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.

Zheng L, Liang P, Li J, Huang XB, Liu SC, Zhao HZ, Han KQ, Wang Z.

PLoS One. 2012;7(9):e45412. doi: 10.1371/journal.pone.0045412. Epub 2012 Sep 25.

PMID:
23049798
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.

Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH.

Hum Pathol. 2012 Jul;43(7):1084-93. doi: 10.1016/j.humpath.2011.08.019. Epub 2011 Dec 26.

PMID:
22204716
[PubMed - indexed for MEDLINE]
16.

Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.

Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ.

Mol Pharmacol. 2013 May;83(5):1109-19. doi: 10.1124/mol.112.083634. Epub 2013 Mar 11.

PMID:
23478801
[PubMed - indexed for MEDLINE]
Free Article
17.

Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo.

Li X, Pan Y, Fan R, Jin H, Han S, Liu J, Wu K, Fan D.

Carcinogenesis. 2008 Aug;29(8):1587-93. doi: 10.1093/carcin/bgn052. Epub 2008 Feb 24.

PMID:
18299278
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.

Ren F, Wu H, Lei Y, Zhang H, Liu R, Zhao Y, Chen X, Zeng D, Tong A, Chen L, Wei Y, Huang C.

Mol Cancer. 2010 Apr 19;9:81. doi: 10.1186/1476-4598-9-81.

PMID:
20403181
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.

Gao YB, Xiang ZL, Zhou LY, Wu ZF, Fan J, Zeng HY, Zeng ZC.

J Cancer Res Clin Oncol. 2013 Apr;139(4):669-79. doi: 10.1007/s00432-012-1370-4. Epub 2013 Jan 10.

PMID:
23307318
[PubMed - indexed for MEDLINE]
20.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk